BioInquire | GenomeWeb

BioInquire

Simultaneous qual-quan workflows generate significantly more data than many conventional mass spec assays, posing a challenge for vendors of ensuring that their software offerings keep pace with the expanded capabilities of their hardware.

The separations products company plans to buy the mass spec analysis software maker for at least $3 million.

The deal, valued at more than $3 million, would provide NuSep with BioInquire's ProteoIQ software, which helps customers identify proteins separated by mass spec instruments.

The firm will use the funding to develop its proteomics software platform.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.